CVE:LXG

LexaGene News Headlines

C$0.76
+0.01 (+1.33 %)
(As of 04/15/2021 03:10 PM ET)
Add
Compare
Today's Range
C$0.75
Now: C$0.76
C$0.77
50-Day Range
C$0.75
MA: C$0.97
C$1.16
52-Week Range
C$0.56
Now: C$0.76
C$1.54
Volume49,430 shs
Average Volume466,198 shs
Market CapitalizationC$86.92 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

LexaGene (CVE LXG) News Headlines Today

SourceHeadline
NA Proactive news snapshot: Golden Tag Resources, TechX Technologies, Viscount Mining, LexaGene UPDATE … - Proactive Investors USA & CanadaNA Proactive news snapshot: Golden Tag Resources, TechX Technologies, Viscount Mining, LexaGene UPDATE … - Proactive Investors USA & Canada
proactiveinvestors.com - April 15 at 1:05 AM
NA Proactive news snapshot: Cloud DX, Golden Tag Resources, TechX Technologies, Viscount Mining, LexaGene UPDATE … - Proactive Investors USANA Proactive news snapshot: Cloud DX, Golden Tag Resources, TechX Technologies, Viscount Mining, LexaGene UPDATE … - Proactive Investors USA
proactiveinvestors.com - April 15 at 1:05 AM
BioMedNewsBreaks – LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) to Host Private Seminar to Present MiQLab Data from Recent Study - StreetInsider.comBioMedNewsBreaks – LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) to Host Private Seminar to Present MiQLab Data from Recent Study - StreetInsider.com
streetinsider.com - April 15 at 1:05 AM
NA Proactive news snapshot: Golden Tag Resources, TechX Technologies, Viscount Mining, LexaGene UPDATE … - Proactive Investors USANA Proactive news snapshot: Golden Tag Resources, TechX Technologies, Viscount Mining, LexaGene UPDATE … - Proactive Investors USA
proactiveinvestors.com - April 14 at 3:03 PM
LexaGene to host veterinary event with UPenn professor presenting a study of MiQLab detecting Staphylococcus in canine skin infections - Proactive Investors USALexaGene to host veterinary event with UPenn professor presenting a study of MiQLab detecting Staphylococcus in canine skin infections - Proactive Investors USA
proactiveinvestors.com - April 14 at 3:03 PM
LexaGene Hosts a Seminar to Present MiQLab Data from Veterinary Samples - GlobeNewswireLexaGene Hosts a Seminar to Present MiQLab Data from Veterinary Samples - GlobeNewswire
globenewswire.com - April 14 at 3:03 PM
BioMedNewsBreaks – LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) Reports Update in Shareholder Letter - StreetInsider.comBioMedNewsBreaks – LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) Reports Update in Shareholder Letter - StreetInsider.com
streetinsider.com - April 2 at 12:14 AM
NA Proactive news snapshot: Vuzix, Cardiol Therapeutics, AgraFlora Organics, ImagineAR, LexaGene, Cloud Nine Web3 UPDATE... - Proactive Investors USA & CanadaNA Proactive news snapshot: Vuzix, Cardiol Therapeutics, AgraFlora Organics, ImagineAR, LexaGene, Cloud Nine Web3 UPDATE... - Proactive Investors USA & Canada
proactiveinvestors.com - April 1 at 7:14 PM
LexaGene Holdings ramps up manufacturing of its flagship MiQLab system - Proactive Investors USALexaGene Holdings ramps up manufacturing of its flagship MiQLab system - Proactive Investors USA
proactiveinvestors.com - April 1 at 2:14 PM
LexaGenes Provides Corporate Update TSX Venture Exchange:LXG - GlobeNewswire - GlobeNewswireLexaGene's Provides Corporate Update TSX Venture Exchange:LXG - GlobeNewswire - GlobeNewswire
globenewswire.com - April 1 at 9:13 AM
Highlights From Day 2 Of Benzingas Biotech Small Cap Conference - BenzingaHighlights From Day 2 Of Benzinga's Biotech Small Cap Conference - Benzinga
benzinga.com - March 26 at 5:41 PM
LexaGene advances its pathogen-detection technology in battle against coronavirusLexaGene advances its pathogen-detection technology in battle against coronavirus
proactiveinvestors.com - March 3 at 11:41 AM
LexaGene says it has received approximately C$3.6M (US$2.9M) in warrant exercises since the start of 2021 - Proactive Investors USA & CanadaLexaGene says it has received approximately C$3.6M (US$2.9M) in warrant exercises since the start of 2021 - Proactive Investors USA & Canada
proactiveinvestors.com - March 2 at 5:43 PM
BioMedNewsBreaks – LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF) Secures $3.6M from Exercised Warrants - StreetInsider.comBioMedNewsBreaks – LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF) Secures $3.6M from Exercised Warrants - StreetInsider.com
streetinsider.com - March 2 at 12:36 PM
LexaGene Receives $3.6M from the Exercise of Warrants - GlobeNewswireLexaGene Receives $3.6M from the Exercise of Warrants - GlobeNewswire
globenewswire.com - March 2 at 12:36 PM
LexaGene Holdings says its president Daryl Rebeck will resign from his position and the boardLexaGene Holdings says its president Daryl Rebeck will resign from his position and the board
proactiveinvestors.com - February 12 at 3:17 PM
Wall Street slides at the opening bellWall Street slides at the opening bell
proactiveinvestors.com - February 12 at 10:16 AM
Lexagene’s MiQLab takes another step forward successfully detecting UK and South African VariantsLexagene’s MiQLab takes another step forward successfully detecting UK and South African Variants
proactiveinvestors.com - February 10 at 5:53 PM
LexaGene successfully configures its MiQLab system to detect mutant sequences unique to UK and South African coronavirus variantsLexaGene successfully configures its MiQLab system to detect mutant sequences unique to UK and South African coronavirus variants
proactiveinvestors.com - February 10 at 5:53 PM
LexaGene Holdings initiates program to identify the UK and South African variants of coronavirusLexaGene Holdings initiates program to identify the UK and South African variants of coronavirus
proactiveinvestors.com - January 14 at 4:48 AM
Why Theres Still Need for Rapid Accessible Pathogen Testing, During and After the CrisisWhy There's Still Need for Rapid Accessible Pathogen Testing, During and After the Crisis
marketwatch.com - January 13 at 1:47 PM
LexaGene starts studies required by the FDA for Emergency Use...LexaGene starts studies required by the FDA for Emergency Use...LexaGene starts studies required by the FDA for Emergency Use...LexaGene starts studies required by the FDA for Emergency Use...
proactiveinvestors.com - January 1 at 8:31 AM
LexaGene Holdings set to deploy its MiQLab Systems at two veterinary hospitals in USLexaGene Holdings set to deploy its MiQLab Systems at two veterinary hospitals in US
proactiveinvestors.com - December 19 at 2:36 PM
LexaGene places MiQLab system in microbiology lab at University of Pennsylvanias School of Veterinary MedicineLexaGene places MiQLab system in microbiology lab at University of Pennsylvania's School of Veterinary Medicine
proactiveinvestors.com - November 20 at 7:55 PM
LexaGene Places MiQLab System at the University of Pennsylvania’s School of Veterinary MedicineLexaGene Places MiQLab System at the University of Pennsylvania’s School of Veterinary Medicine
markets.businessinsider.com - November 18 at 1:17 PM
LexaGene receives purchase order for a MiQLab system from a multinational biotechnology companyLexaGene receives purchase order for a MiQLab system from a multinational biotechnology company
proactiveinvestors.com - November 16 at 2:05 PM
LexaGene to Present at Two Upcoming Investor ConferencesLexaGene to Present at Two Upcoming Investor Conferences
markets.businessinsider.com - November 16 at 12:11 AM
LexaGene Announces Results of Annual General Shareholder’s MeetingLexaGene Announces Results of Annual General Shareholder’s Meeting
markets.businessinsider.com - November 13 at 5:32 PM
Could LexaGene Holdings pathogen detection platform be a difference-maker in the fight against COVID-19?Could LexaGene Holdings' pathogen detection platform be a difference-maker in the fight against COVID-19?
proactiveinvestors.com - October 21 at 8:34 AM
LexaGene Provides a Corporate UpdateLexaGene Provides a Corporate Update
nasdaq.com - October 5 at 7:35 PM
LexaGene unveils early access program for pathogen-detecting MiQLab system; progresses toward automated coronavirus test - Proactive Investors USA & CanadaLexaGene unveils early access program for pathogen-detecting MiQLab system; progresses toward automated coronavirus test - Proactive Investors USA & Canada
proactiveinvestors.com - October 5 at 2:34 PM
LexaGene Provides a Corporate Update TSX Venture Exchange:LXG - GlobeNewswireLexaGene Provides a Corporate Update TSX Venture Exchange:LXG - GlobeNewswire
globenewswire.com - October 5 at 9:33 AM
LexaGene announces appointment of Dr Shelley Rankin to its Scientific Advisory Board; CEO delivers video message - Proactive Investors USA & CanadaLexaGene announces appointment of Dr Shelley Rankin to its Scientific Advisory Board; CEO delivers video message - Proactive Investors USA & Canada
proactiveinvestors.com - September 21 at 7:35 PM
BioMedNewsBreaks – LexaGene Holdings, Inc. (TSX.V: LXG) (OTCQB: LXXGF) Announces Engagement of Tailwinds Research Group, Video Update and Strategic Advisory Board Appointment - StreetInsider.comBioMedNewsBreaks – LexaGene Holdings, Inc. (TSX.V: LXG) (OTCQB: LXXGF) Announces Engagement of Tailwinds Research Group, Video Update and Strategic Advisory Board Appointment - StreetInsider.com
streetinsider.com - September 21 at 2:33 PM
LexaGene announces appointment of Dr Shelley Rankin to its Scientific Advisory Board - Proactive Investors USA & CanadaLexaGene announces appointment of Dr Shelley Rankin to its Scientific Advisory Board - Proactive Investors USA & Canada
proactiveinvestors.com - September 21 at 9:33 AM
LexaGenes CEO Provides Video Message on Companys Progress and Announces Appointment of Dr. Shelley Rankin to Companys Scientific Advisory Board - GlobeNewswireLexaGene's CEO Provides Video Message on Company's Progress and Announces Appointment of Dr. Shelley Rankin to Company's Scientific Advisory Board - GlobeNewswire
globenewswire.com - September 21 at 9:33 AM
LexaGene Engages Tailwinds Research Group - Yahoo FinanceLexaGene Engages Tailwinds Research Group - Yahoo Finance
finance.yahoo.com - September 20 at 1:10 PM
IIROC Trading Resumption - BABY - yahoo.comIIROC Trading Resumption - BABY - yahoo.com
finance.yahoo.com - September 18 at 3:43 PM
LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) Featured in Virtual Coverage of The Wall Street Investor Forum - StreetInsider.comLexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) Featured in Virtual Coverage of The Wall Street Investor Forum - StreetInsider.com
streetinsider.com - September 10 at 12:32 PM
BioMedNewsBreaks – LexaGene Holdings, Inc. (TSX.V: LXG) (OTCQB: LXXGF) Secures C$13.29M Through Previously Announced Offering - StreetInsider.comBioMedNewsBreaks – LexaGene Holdings, Inc. (TSX.V: LXG) (OTCQB: LXXGF) Secures C$13.29M Through Previously Announced Offering - StreetInsider.com
streetinsider.com - September 10 at 12:32 PM
LexaGene Holdings Announces Closing of CAD$13.29 Million FinancingLexaGene Holdings Announces Closing of CAD$13.29 Million Financing
finance.yahoo.com - September 10 at 7:31 AM
LexaGene Holdings closes on C$13.29M in financing to build inventory and expand sales - Proactive Investors USA & CanadaLexaGene Holdings closes on C$13.29M in financing to build inventory and expand sales - Proactive Investors USA & Canada
proactiveinvestors.com - September 9 at 1:59 PM
LexaGene looking to raise aggregate gross proceeds of about C$11.5 million from up-sized bought deal unit offering - Proactive Investors USA & CanadaLexaGene looking to raise aggregate gross proceeds of about C$11.5 million from up-sized bought deal unit offering - Proactive Investors USA & Canada
proactiveinvestors.com - August 19 at 5:18 PM
LexaGene Holdings upsizes bought deal financing to C$11.56M - Seeking AlphaLexaGene Holdings upsizes bought deal financing to C$11.56M - Seeking Alpha
seekingalpha.com - August 19 at 12:18 PM
LexaGene looking to raise aggregate gross proceeds of approximately C$7,500,000 from a bought deal unit offering - Proactive Investors USA & CanadaLexaGene looking to raise aggregate gross proceeds of approximately C$7,500,000 from a bought deal unit offering - Proactive Investors USA & Canada
proactiveinvestors.com - August 19 at 12:18 PM
LexaGene Announces $7.5 Million Bought Deal Public Offering - Yahoo FinanceLexaGene Announces $7.5 Million Bought Deal Public Offering - Yahoo Finance
finance.yahoo.com - August 19 at 7:17 AM
LexaGene announces $7.5M bought deal public offering - Seeking AlphaLexaGene announces $7.5M bought deal public offering - Seeking Alpha
seekingalpha.com - August 18 at 9:13 PM
LexaGene Holdings hires contract manufacturer LaunchWorks to support MiQLab launch - Proactive Investors USA & CanadaLexaGene Holdings hires contract manufacturer LaunchWorks to support MiQLab launch - Proactive Investors USA & Canada
proactiveinvestors.com - August 17 at 12:53 PM
Testing’s Critical Role in Stemming the TideTesting’s Critical Role in Stemming the Tide
finance.yahoo.com - July 23 at 2:55 PM
Testings Critical Role in Stemming the Tide TSX Venture Exchange:LXG - GlobeNewswireTesting's Critical Role in Stemming the Tide TSX Venture Exchange:LXG - GlobeNewswire
www.globenewswire.com - July 22 at 12:40 PM
This page was last updated on 4/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.